126 related articles for article (PubMed ID: 15883266)
21. Monetary costs of dementia in the United States.
Hurd MD; Martorell P; Delavande A; Mullen KJ; Langa KM
N Engl J Med; 2013 Apr; 368(14):1326-34. PubMed ID: 23550670
[TBL] [Abstract][Full Text] [Related]
22. 2024 Alzheimer's disease facts and figures.
Alzheimers Dement; 2024 May; 20(5):3708-3821. PubMed ID: 38689398
[TBL] [Abstract][Full Text] [Related]
23. Unlocking the Potential of Repetitive Transcranial Magnetic Stimulation in Alzheimer's Disease: A Meta-Analysis of Randomized Clinical Trials to Optimize Intervention Strategies.
Li S; Lan X; Liu Y; Zhou J; Pei Z; Su X; Guo Y
J Alzheimers Dis; 2024; 98(2):481-503. PubMed ID: 38427480
[TBL] [Abstract][Full Text] [Related]
24. Exploring the association between cancer and cognitive impairment in the Australian Imaging Biomarkers and Lifestyle (AIBL) study.
Ma L; Low YLC; Zhuo Y; Chu C; Wang Y; Fowler CJ; Tan ECK; Masters CL; Jin L; Pan Y
Sci Rep; 2024 Feb; 14(1):4364. PubMed ID: 38388558
[TBL] [Abstract][Full Text] [Related]
25. GV1001 reduces neurodegeneration and prolongs lifespan in 3xTg-AD mouse model through anti-aging effects.
Park HH; Kwon HS; Lee KY; Kim YE; Son JW; Choi NY; Han MH; Park DW; Kim S; Koh SH
Aging (Albany NY); 2024 Jan; 16(3):1983-2004. PubMed ID: 38301041
[TBL] [Abstract][Full Text] [Related]
26. Alzheimer's Disease: Models and Molecular Mechanisms Informing Disease and Treatments.
Nystuen KL; McNamee SM; Akula M; Holton KM; DeAngelis MM; Haider NB
Bioengineering (Basel); 2024 Jan; 11(1):. PubMed ID: 38247923
[TBL] [Abstract][Full Text] [Related]
27. A common molecular and cellular pathway in developing Alzheimer and cancer.
Ali M; Wani SUD; Dey T; Sridhar SB; Qadrie ZL
Biochem Biophys Rep; 2024 Mar; 37():101625. PubMed ID: 38225990
[TBL] [Abstract][Full Text] [Related]
28. Hemoglobin A1c Serum Level Predicts 5-year Mortality in Patients with Cognitive Impairment.
Dreier J; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
J Diabetes Metab Disord; 2023 Dec; 22(2):1705-1714. PubMed ID: 37969915
[TBL] [Abstract][Full Text] [Related]
29. Primary care detection of cognitive impairment leveraging health and consumer technologies in underserved US communities: protocol for a pragmatic randomised controlled trial of the MyCog paradigm.
Lovett R; Bonham M; Yoshino Benavente J; Hosseinian Z; Byrne GJ; Varela Diaz M; Bass M; Yao L; Adin-Cristian A; Batio S; Kim M; Sluis A; Moran M; Buchanan DR; Hunt J; Young SR; Gershon R; Nowinski C; Wolf M
BMJ Open; 2023 Oct; 13(10):e080101. PubMed ID: 37852774
[TBL] [Abstract][Full Text] [Related]
30. Predicting sojourn times across dementia disease stages, institutionalization, and mortality.
Tate AE; Bouteloup V; van Maurik IS; Jean D; Mank A; Speh A; Boilet V; van Harten A; Eriksdotter M; Wimo A; Dufouil C; van der Flier WM; Jönsson L
Alzheimers Dement; 2024 Feb; 20(2):809-818. PubMed ID: 37779086
[TBL] [Abstract][Full Text] [Related]
31. Clinical profile and survival analysis of Alzheimer's disease patients in a Brazilian cohort.
de Melo Queiroz E; Marques Couto C; da Cruz Mecone CA; Souza Lima Macedo W; Caramelli P
Neurol Sci; 2024 Jan; 45(1):129-137. PubMed ID: 37540343
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and risk factors of mild cognitive impairment in a tertiary care setting in Turkey.
Yavuz Veizi BG; Avci C; Yazir HT; Naharci MI
Z Gerontol Geriatr; 2024 Mar; 57(2):113-119. PubMed ID: 37115225
[TBL] [Abstract][Full Text] [Related]
33. Effect of mortality in cost-effectiveness modeling of disease-modifying treatment for Alzheimer's disease.
Aye S; Jönsson L; Gustavsson A; Tate A; Ptacek SG; Eriksdotter M
Alzheimers Dement (Amst); 2023; 15(1):e12422. PubMed ID: 37009338
[TBL] [Abstract][Full Text] [Related]
34. Olfactory identification, cognition, depressive symptoms, and 5-year mortality in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer's disease.
Pusswald G; Dapić B; Bum C; Schernhammer E; Stögmann E; Lehrner J
Wien Med Wochenschr; 2024 Apr; 174(5-6):95-106. PubMed ID: 36917318
[TBL] [Abstract][Full Text] [Related]
35. Causes of Mortality in Korean Patients with Neurodegenerative Dementia.
Choi HG; Park B; Kim JH; Kim JH; Kwon MJ; Kim M
Biomed Res Int; 2022; 2022():3206594. PubMed ID: 35509710
[TBL] [Abstract][Full Text] [Related]
36. Association of Education and Intracranial Volume With Cognitive Trajectories and Mortality Rates Across the Alzheimer Disease Continuum.
van Loenhoud AC; Groot C; Bocancea DI; Barkhof F; Teunissen C; Scheltens P; van de Flier WM; Ossenkoppele R
Neurology; 2022 Apr; 98(16):e1679-e1691. PubMed ID: 35314498
[TBL] [Abstract][Full Text] [Related]
37. No effect of thyroid hormones on 5-year mortality in patients with subjective cognitive decline, mild cognitive disorder, and Alzheimer's disease.
Đapić B; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
J Neuroendocrinol; 2022 Apr; 34(4):e13107. PubMed ID: 35213057
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Disease Registries on Advancing Knowledge and Understanding of Dementia Globally.
Heikal SA; Salama M; Richard Y; Moustafa AA; Lawlor B
Front Aging Neurosci; 2022; 14():774005. PubMed ID: 35197840
[TBL] [Abstract][Full Text] [Related]
39. Primary Palliative Care in Dementia.
Weisbrod N
Neurotherapeutics; 2022 Jan; 19(1):143-151. PubMed ID: 35080735
[TBL] [Abstract][Full Text] [Related]
40. Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease.
Schaffert J; LoBue C; Hynan LS; Hart J; Rossetti H; Carlew AR; Lacritz L; White CL; Cullum CM
J Alzheimers Dis; 2022; 86(1):271-281. PubMed ID: 35034898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
